Stem Cell Therapy for Tissue Regeneration
Stem Cell Culture
iPS Cell Differentiation
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Xiaomei Chen1, Bowen Liu1, Chao Li1
1Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, PR China.
干细胞疗法在治疗COVID-19造成的肺损伤方面表现有前途,并可能作为一种新型疫苗. 这篇评论探讨了干细胞机制,临床试验和用于预防COVID-19的工程外细胞囊泡.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: